Clinical trial
OTO-MATIC: Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children
NCT06285812 is registered in ClinicalTrials.gov with PhotoniCare, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OTO-MATIC: Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children
- Lead sponsor
- PhotoniCare, Inc.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 10, 2024
- Completion date
- July 31, 2026
- Enrollment
- 700 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
otitis media acute